I would say it is kind of embarrassing to even consider

New Post Public Reply Private Reply Replies (2) Message Board
Goosebumps KenChowder #105657
564
I would say it is kind of embarrassing to even consider such a 13d group. Have they not shown who they really are to everyone and their brother? The informed investor know who they are. Is there any doubt in their honesty? Definitely full of lies and smoke and mirrors in their path getting to this point. Can we trust their path forward. Are we sure they will do what they say they will do? Can we even believe anything they say? Do we typically follow dishonest leaders? I know… I do not follow someone who lies to me. The old sayin holds true for me… Fool me once and shame on you… Fool me twice and shame on me… They admitted their lies recently. Have we not all have been fooled at least once by their own admissions in their settlement of all the misinformation and outright lies they had to come clean on to settle the first lawsuit. Do you still trust this group? Why would you? What makes you trust a group that has lied to you? Do we forgive their lies? How do you forgive them? How do you trust them in the future?

Are they good leaders when they can’t decide proper priorities of which direction is needed for our company to be successful? When you can not figure out what direction to progress the company or which indications should be first… do we follow this 13d groups possible mismanagement? Will we really only have one trial indication at a time? How destructive would it be to stop all other trials and just focus on an arrogant doctors swan song trial only. When we have at minimal costs continuing all trials and potential revenue much sooner. Long haulers has its place and as soon as we can start the trial the better. But it is ignorance to stop our other trials. To wait until we get revenue from Long Haulers could bury us in dilution or maybe just bankrupt us. Is bankruptcy their true plan? It would be the smart as a fox way of intentionally going to bankruptcy. One where shareholders have no recourse. Then the liquidation sale they won’t speak too. Why won’t they address the claim? Can’t admit it now if this is their underlying plan or they do face shareholders recourse.

Having more irons in the fire is just good business and our management is doing everything right with the right priorities. Does the 13d group think that their path is sellable to the investors? They are not very convincing with a huge bet put on Long Haulers to be our first approval of any kind. Does this not mean we will stop all other trials that could achieve approval of some kind before Long haulers. Does this seem like an intelligent path?

Let’s compare our current management. Will they continue to be able to finance our trials until we receive our first approval? There is no doubt or very little risk. How soon could we see an approval on our managements path foreword? Maybe as son as 2-3 months. Will we continue all of our current trials? I believe that is our path and superior choice of direction forward. Has our current management told of us of our long term future? Yes they have. The 13d group has not committed to a long term future direction for our company. This is a serious flaw for them. Our current management has told us their long term plan is to grow our company into our own pharmaceutical company. Do not underestimate just how important this future is. There is not a better plan that we could have. The most return on our investment is growing into our own big pharmaceutical company and their is no argument about this. Becoming our own big Pharma is the best option we have to see the wealth of what our investment can do for us.

The 13d group gave us a 2 year plan with possible approval on Long Haulers. We all hope that Long Haulers is huge but do we bet our whole investment on it? We don’t know if they understand financing needed to continue our path forward to approval. The finance guy did not impress in his segment of the last call. Financing would be everything for them if we had to wait as long as two years for an approval on Long Haulers. They have not said definitively that they could receive a EUA for Long Haulers. Ohm says it’s not possible. Then can we wait almost two years for an approval?

Have I provided enough doubt about the 13d group to scare you? If your not scared now… you don’t have enough invested to become scared. Those of us that do are scared shitless of this unproven, lying, un-trustable inexperienced group. They have never ran a biotech company or a pharmaceutical company. They won’t tell you who the interim CEO will be? Why is that? It will cost them dearly in votes is why. My bet it is the less than believable Rosenbaum himself. If this isn’t a self destruction mode of a company to appoint a CEO of his unqualified experience. What a joke this would be. Ask yourself who else it would be? It’s not Patterson. He is the new CMO in their plan. Ask yourself why no CEO yet. Yep… more smoke and mirrors…more lies to come…

It’s just a rant that I have to speak to or it builds up inside of me and just flat pisses me off. Screw that 13d group and the horse they rode in on! Vote our current management and become rich for it.

There… is there any doubt in which way I lean?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSL Names Deborah Waterhouse as CEO in Strategic Move

Updated Category News Views 8

A Key Transition: Deborah Waterhouse Takes the Helm In a move that's sure to jolt the biopharma sphere, CSL Limited just handed the CEO reins over to Deborah Waterhouse. Set to start officially on February 1, 2027, this strategic appointment seems well plotted after a diligent global hunt by CSL's board for someone who can drive their enterprise into its next surge of...

Continue Reading
Bolt Teams with NVIDIA for Europe AV Expansion

Updated Category News Views 2

Racing Towards an Autonomous Future Well, hold onto your seats because the European roads will soon witness one hell of a technological trip—with an autonomous twist. Bolt, in cahoots with NVIDIA and Lucid, is plotting to roll out a massive fleet of autonomous vehicles just gearing up to hit the streets. The project's kicking off in Madrid in 2027 and aims to sprinkle...

Continue Reading
Ashford Hospitality Trust: Fee Waiver and Share Buyback

Updated Category News Views 3

Strategic Moves in a Challenging Market When it rains, it pours. Ashford Hospitality Trust (NYSE: AHT), the real estate investment trust that's got its fingers in the hotel industry pie, is shaking things up with some bold maneuvers. The company just dropped a bombshell: it's waiving a $17 million advisory fee, buying back shares, and terminating its at-the-market (ATM)...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 9

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Partner Climbs 25 Spots on ENR's Environmental Firm List

Updated Category News Views 11

A Leap Forward in Environmental Expertise Alright, folks, let's dive into some real grit. Partner Engineering and Science, Inc. has pulled off a neat little trick. They've jumped up 25 spots on the 2026 Engineering News-Record's Top 200 Environmental Firms list. They’ve been making this list for 14 years straight, and that's no fluke. It's a hard road, especially when...

Continue Reading
Network Brainiacs Expands Footprint into Maryland Market

Updated Category News Views 10

Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...

Continue Reading
Glint: Lovense's New Era in Intimacy Tech

Updated Category News Views 6

From Thrill to Touch: The Glint Debut Screw the traditional remote control for sex toys! Lovense is straight up flipping the script with Glint. This isn't about adding more buttons or connecting another app. We're talking about a butt plug that lets your partner's thrust set the whole vibe. Forget fumbling with phones in the heat of the moment—this toy syncs your...

Continue Reading
Millrose Investors Face Unveiling of Financial Missteps

Updated Category News Views 11

A Cold Shower for Millrose Properties' Investors Investing in Millrose Properties, Inc. (NYSE: MRP) didn't quite pan out as some folks hoped. On the heels of Hunterbrook's report about dubious deals, the Company's stock tumbled 8.53%, smacking investors with a not-so-gentle reminder of market realities. Sure, stocks can dip and dive like a rollercoaster, but when it...

Continue Reading
Oberndorf, Bascom Snap Up San Jose Flats for $53M

Updated Category News Views 11

Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...

Continue Reading
Papa John's Legal Woes: Class Action Lawsuit Hits Hard

Updated Category News Views 6

A Hot Slice of Legal Trouble for Papa John's Ah, what a steaming mess Papa John's seems to have landed in! And not the good kind with extra cheese. The lawsuit bell tolls for them, reminding investors that even the big guys can get burned. This time, it's for allegedly not having their story straight when it came to market expectations and promotional tactics. Under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Great Rock Capital Increases Leverage Facility to Over $700M

Updated Category News Views 140

Great Rock Capital Enhances Leverage Facility Great Rock Capital, a notable player in the arena of asset-focused commercial finance, has recently made headlines by increasing its leverage facility beyond $700 million. This financing initiative, supported by KeyBank National Association, stands as a testament to the company’s commitment towards fostering growth within...

Continue Reading
Iran's Strategic Response to Recent Israeli Military Actions

Updated Category News Views 117

Iran's Commitment to Retaliation In a recent statement, the Iranian Foreign Ministry has affirmed its position to utilize all available resources in response to Israel's recent military actions against its territories. Spokesperson Esmaeil Baghaei emphasized that Iran is prepared to deliver a strong and decisive reply to the Israeli regime following their latest...

Continue Reading
Understanding Voting Rights and Capital for Investors Today

Updated Category News Views 175

Understanding Voting Rights and Capital for Investors When it comes to investing in companies, understanding the structure of their share capital is vital. One such company is Octopus AIM VCT 2 plc, known for its unique investment opportunities. This company has recently shared an important update regarding its share capital and total voting rights, which offers valuable...

Continue Reading
Victoria's Secret & Co. Achieves Strong Fourth Quarter Growth

Updated Category News Views 178

Victoria's Secret & Co. Reports Impressive Fourth Quarter Performance Victoria's Secret & Co. (NYSE: VSCO) has published its financial results for the fourth quarter, highlighting a strong performance that exceeded many expectations. The company experienced a 5% increase in comparable sales, driven by robust growth across both the Victoria's Secret and PINK brands,...

Continue Reading
JetCat Turbines Americas Pursues Justice in Contract Dispute

Updated Category News Views 433

JetCat Turbines Americas Takes Legal Action Jacksonville, FL — JetCat Turbines Americas has recently initiated a lawsuit against Ingenieurbüro CAT, M. Zipperer GmbH, commonly known as JetCat Germany. This legal step was taken in the U.S. District Court for the Southern District of Florida and is spearheaded by Transnational Matters PLLC, a law firm specializing in...

Continue Reading